3D Hepatocyte Hydrogel Tissue for Sustained Liver Function

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Hepatocytes, when cultured in two-dimensional environments, rapidly dedifferentiate and lose their unique functions, with insufficient maintenance of metabolic enzyme expression and bile canalicular structure production in conventional three-dimensional cultures.

Innovation Solution

A three-dimensional hepatic tissue is produced by aggregating hepatocytes within a hydrogel without hepatic stellate cells, using a hydrogel such as fibrin, and optionally including extracellular matrix components like collagen and polyelectrolytes like heparin, to maintain metabolic enzyme expression and form functional structures like bile canaliculi.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If hepatocytes are cultured in a conventional two-dimensional environment, then the culture process is simple, but the hepatocytes rapidly dedifferentiate and lose their unique functions

Engineering Contradiction:
Improveculture process simplicityVSAvoidmaintenance of hepatocyte function
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent transitions from two-dimensional planar culture to three-dimensional spheroid culture by aggregating hepatocytes into spherical structures. This dimensional change allows hepatocytes to self-organize into a more physiologically relevant architecture, maintaining cell-cell interactions and preventing dedifferentiation while preserving the relative simplicity of the culture process.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If hepatocytes are cultured in conventional three-dimensional structures, then the three-dimensional organization is achieved, but the expression of metabolic enzymes and production of bile canalicular structures are insufficient

Engineering Contradiction:
Improvemaintenance of hepatocyte functionVSAvoidexpression of metabolic enzymes and bile canalicular structures
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent optimizes specific parameters including spheroid size (0.5-5 mm diameter), culture duration (7-14 days), and medium composition to enhance hepatocyte function. These parameter adjustments enable the three-dimensional spheroids to achieve adequate metabolic enzyme expression and bile canalicular structure formation.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a two-stage culture approach where hepatocytes are first aggregated into spheroids, then maintained in suspension culture for a specific period before analysis. This preliminary organization into three-dimensional structures prepares the cells to maintain their functional characteristics throughout the culture period.

Inventive Principle:
Principle #10Preliminary action

3Reliability

If co-culture systems with multiple cell types are used, then cell function is improved by mimicking in vivo composition, but the device complexity increases

Engineering Contradiction:
Improvecell function enhancementVSAvoidculture system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and focuses on the essential requirement for three-dimensional organization by using hepatocyte-only spheroids. This approach eliminates the complexity of co-culture systems while maintaining the key benefit of three-dimensional cell organization, demonstrating that spheroid formation alone is sufficient to preserve hepatocyte function.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method sustains high expression of metabolic enzymes like CYP3A4 and CYP2C9, and adequately produces bile canaliculi, creating a more functional three-dimensional hepatic tissue.

Implementation Method 1

a three-dimensional hepatic tissue including a cell structure containing at least hepatocytes, and a hydrogel, wherein the cell structure does not contain hepatic stellate cells, and the cell structure is embedded in the hydrogel

Methodology Applied
Scientific EffectHydrogel: Hydrogel

Implementation Method 2

In order to maintain cellular organization, an extracellular matrix (ECM) such as collagen produced by the living body itself is required for intercellular binding and scaffold formation

Methodology Applied
Scientific EffectExtracellular matrix:

Data Source

PatentEP4667562A1Three-dimensional hepatocyte tissue and method for producing same
Publication Date: 2025.12.24 TOPPAN HOLDINGS INC
  • EP4667562A1 patent drawingFigure 1(A)~1(B)
  • EP4667562A1 patent drawingFigure 2
  • EP4667562A1 patent drawingFigure 3

AI summary

The present invention relates to a three-dimensional hepatic tissue comprising a cell structure containing at least hepatocytes, and a hydrogel, wherein the cell structure does not contain hepatic stellate cells, and the cell structure is embedded in the hydrogel.